Keytru­da adds new FDA ap­proval for a rare form of mesothe­lioma

Keytru­da is al­ready ap­proved in more than 40 dif­fer­ent on­col­o­gy in­di­ca­tions, but its lat­est la­bel ex­pan­sion is a first for the can­cer block­buster.

Mer­ck …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER